🇺🇸 FDA
Patent

US 6808702

Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs

expired A61KA61K35/12A61P

Quick answer

US patent 6808702 (Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs) held by The Board of Regents of the University of Texas System expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K35/12, A61P, A61P1/00, A61P1/16